- Home
- MSM vs BBIO Comparison
MSM vs BBIO Comparison
Compare MSM & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSM
- BBIO
- Stock Information
- Founded
- MSM 1941
- BBIO 2015
- Country
- MSM United States
- BBIO United States
- Employees
- MSM N/A
- BBIO N/A
- Industry
- MSM Industrial Machinery/Components
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- MSM Industrials
- BBIO Health Care
- Exchange
- MSM Nasdaq
- BBIO Nasdaq
- Market Cap
- MSM 4.7B
- BBIO 5.1B
- IPO Year
- MSM 1995
- BBIO 2019
- Fundamental
- Price
- MSM $80.98
- BBIO $27.30
- Analyst Decision
- MSM Hold
- BBIO Strong Buy
- Analyst Count
- MSM 5
- BBIO 13
- Target Price
- MSM $81.00
- BBIO $47.92
- AVG Volume (30 Days)
- MSM 494.8K
- BBIO 2.5M
- Earning Date
- MSM 01-07-2025
- BBIO 11-12-2024
- Dividend Yield
- MSM 4.21%
- BBIO N/A
- EPS Growth
- MSM N/A
- BBIO N/A
- EPS
- MSM 4.58
- BBIO N/A
- Revenue
- MSM $3,820,951,000.00
- BBIO $217,765,000.00
- Revenue This Year
- MSM N/A
- BBIO $2,648.47
- Revenue Next Year
- MSM $4.68
- BBIO N/A
- P/E Ratio
- MSM $17.76
- BBIO N/A
- Revenue Growth
- MSM N/A
- BBIO 2209.77
- 52 Week Low
- MSM $75.05
- BBIO $21.62
- 52 Week High
- MSM $104.76
- BBIO $44.32
- Technical
- Relative Strength Index (RSI)
- MSM 40.22
- BBIO 57.33
- Support Level
- MSM $80.64
- BBIO $27.17
- Resistance Level
- MSM $83.66
- BBIO $29.99
- Average True Range (ATR)
- MSM 1.69
- BBIO 1.15
- MACD
- MSM -0.38
- BBIO -0.00
- Stochastic Oscillator
- MSM 12.31
- BBIO 47.66
About MSM MSC Industrial Direct Company Inc.
MSC Industrial Direct is one of the largest industrial distributors with a focus on metalworking and maintenance, repair, and operations products and services. The company offers over 2 million products through its distribution network, which has 11 fulfillment centers. Although MSC has a presence in Canada, Mexico, and the United Kingdom, it primarily operates in the United States. In fiscal 2023, 95% of the firm's $4.0 billion of sales was generated in the US.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.